semaglutide from india Indian drugmakers flood market with cheaper versions of Novo's Ozempic, Wegovy Novo Nordisk Launches Ozempic in

This cohort study aims to determine whether use of glucagon-like peptide 1 receptor agonists are associated with lower risk of developing cirrhosis and its complications, including decompensation and hepatocellular cancer, among patients with ...

That same year, the American Diabetes Association updated its guidelines to make GLP-1s a first-line therapy for type 2 diabetesfurther increasing demand

Numerous drugmakers have been racing to develop oral versions of GLP-1 drugs for weight loss

Discover why Europe bans this sugar-killer and what 2026 data reveals for diabetics

The convenience and lower cost of the oral pill may be critical to some patients, which could expand the market, improve adherence and boost long-term outcomes.

Frustrating?